Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00002652
First received: November 1, 1999
Last updated: February 1, 2013
Last verified: April 2002
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2004
  Estimated Primary Completion Date: No date given